Not surprisingly, the role of IGFBP family members in cancer is controversial: They were proposed as inhibitors, but elevated IGFBP‐3 serum levels predicted increased incidence of CRC [47] and high IGFBP3 gene expression was associated with poor overall survival [48]. The gene discussed is IGFBP3; the disease is colorectal carcinoma.